Article citationsMore>>
Müller, L., Kannenberg, J., Biemann, R., Honemann, M., Ackermann, G. and Jassoy, C. (2022) Comparison of the Measured Values of Quantitative SARS-CoV-2 Spike Antibody Assays. Journal of Clinical Virology, 155, Article ID: 105269.
https://doi.org/10.1016/j.jcv.2022.105269
has been cited by the following article:
-
TITLE:
Waning of Anti-Spike IgG Antibody Titer after COVID-19 Vaccination: Myth or Reality?
AUTHORS:
Laurent Dupoirieux
KEYWORDS:
SARS-CoV-2, COVID-19 Vaccines, Anti-Spike IgG Antibodies
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.11 No.8,
August
8,
2023
ABSTRACT: This observational prospective study was conducted on 25 patients who had received a full 3-dose COVID-19 vaccination scheme with a follow-up ranging from 12 to 19 months after the last injection. The aim of the study was focused on a single biological indicator the anti-spike IgG antibody titer. The age of the patients ranged from 51 to 85 years old. 15 out 25 patients (60%) presented a comorbidity. Our data showed a persistent positive anti-spike IgG antibodies titer ranging from 105 to 5680 BAU/mL (mean: 2661 BAU/mL) in all patients. In view of these results, systematic administration of a SARS-CoV-2 vaccine booster is questionable and should be individually tailored according to the patient medical condition and the anti-spike IgG antibody level.
Related Articles:
-
Carlos David A. Bichara, Ednelza S. G. Amoras, Gergiane L. Vaz, Cléa N. C. Bichara, Isabella P. C. Amaral Amaral, Antonio C. R. Vallinoto
-
Michelle Fuentes-Acosta, Jorge Mulia-Rodríguez, Daniel Osorio-González
-
Jinguo Zhu
-
Takuma Tsuzuki Wada, Kazuhiro Yokota, Norihito Tarumoto, Shigefumi Maesaki, Tomoaki Tomiya, Takuya Maeda, Toshihide Mimura
-
Kelly Cremer, Julie Frère, Olga Chatzis, Ricardo De Mendonca, Benoît Kabamba, Florence Renard, Mathilde De Keukeleire, Dimitri Van der Linden, Annie Robert